Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

DXCM holding history

Dexcom Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings

Shares (Q2 2026)
1,211,767
Value
$81.6M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of DXCM by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,211,767$81.6M<0.1%−880,105−42.1%ReducedHolders
Q1 20262,091,872$131.4M0.1%+2,004,972+2,307.2%AddedHolders
Q4 202586,900$5.77M<0.1%−6,691,590−98.7%ReducedHolders
Q3 20256,778,490$456.1M0.4%+5,409,762+395.2%AddedHolders
Q2 20251,368,728$119.5M0.1%−758,695−35.7%ReducedHolders
Q1 20252,127,423$145.3M0.1%−2,134,018−50.1%ReducedHolders
Q4 20244,261,441$331.4M0.3%+3,027,597+245.4%AddedHolders
Q3 20241,233,844$82.7M0.1%+505,959+69.5%AddedHolders
Q2 2024727,885$82.5M0.1%+35,503+5.1%AddedHolders
Q1 2024692,382$96.0M0.1%−1,683,378−70.9%ReducedHolders
Q4 20232,375,760$294.8M0.3%+1,432,110+151.8%AddedHolders
Q3 2023943,650$88.0M0.1%+685,606+265.7%AddedHolders
Q2 2023258,044$33.2M<0.1%−3,780,330−93.6%ReducedHolders
Q1 20234,038,374$469.2M0.5%+1,805,530+80.9%AddedHolders
Q4 20222,232,844$252.8M0.3%+1,583,317+243.8%AddedHolders
Q3 2022649,527$52.3M0.1%−2,421,347−78.8%ReducedHolders
Q2 20223,070,874$228.9M0.3%+1,818,470+145.2%AddedConverted for a 4-for-1 splitHolders
Q1 2022313,101$160.2M0.2%+164,176+110.2%AddedHolders
Q4 2021148,925$80.0M0.1%−34,923−19.0%ReducedHolders
Q3 2021183,848$100.5M0.1%+179,527+4,154.8%AddedHolders
Q2 20214,321$1.84M<0.1%−122,557−96.6%ReducedHolders
Q1 2021126,878$45.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.